Esmet Tablet 50/500 mg

Adult dose

This medication is generally taken twice daily with meals. - For patients not previously treated with metformin: Take this medication 50/500 mg twice a day, 1 tablet each time, and it can be increased to 50/1000 mg twice a day, 1 tablet each time. - For patients receiving treatment with metformin: The recommended total daily dose is sitagliptin 50 mg twice a day (total 100 mg) combined with the existing dose of metformin.

This medication may cause severe allergic reactions after administration, so if symptoms such as skin rash, hives, or difficulty breathing occur, use should be stopped immediately and a physician consulted. Additionally, serious pancreatic disease, such as pancreatitis, can rarely occur, so if sudden abdominal pain, nausea, or vomiting occurs, it is important to inform healthcare personnel immediately. This medication should not be used in patients with moderate to severe kidney dysfunction or those at risk of acute renal failure, and periodic kidney function tests should be performed; if abnormalities are detected, administration must be discontinued. Patients with heart failure or unstable cardiovascular conditions, as well as those with severe infections or dehydration, should not use this medication. This medication should not be used by women who are pregnant or breastfeeding, and safety and efficacy have not been established for children and adolescents under 18 years of age. During the administration of this medication, symptoms of hypoglycemia should be carefully monitored, particularly when used with other hypoglycemic agents or insulin, as the risk of hypoglycemia may increase, necessitating frequent blood sugar checks. Additionally, gastrointestinal side effects such as diarrhea, nausea, vomiting, and abdominal pain may occur with this medication; if symptoms are severe, consultation with a physician is recommended. Alcohol consumption may increase the risk of side effects from this medication, so it is important not to overindulge during administration. Administration of this medication should be suspended for a period before and after surgery, and should only resume once the patient's condition is stabilized and kidney function is confirmed to be normal. While taking this medication, regular blood tests and kidney function tests are necessary to detect abnormalities early and take appropriate action. Drug interactions may occur when combined with certain medications; therefore, it is essential to inform healthcare personnel of any other medications being taken. Finally, it is very important for patients taking this medication and their guardians to fully understand the potential side effects and symptoms, and to consult healthcare personnel immediately if any abnormal symptoms occur.

Serious side effects

Hives, severe swelling (angioedema), chest tightness, difficulty breathing, anaphylaxis, angioedema, exfoliative skin diseases including Stevens-Johnson syndrome, severe rash accompanied by fever, blistering, peeling skin, pain in the oral/ocular mucosa, severe skin adverse reactions, breathlessness or difficulty breathing, asthma attacks, respiratory issues accompanied by cough and fever, yellowing of the skin or eyes (jaundice), liver dysfunction (jaundice), sudden

Mild side effects

Diarrhea, nausea, vomiting, abdominal pain, upper respiratory infection, nasopharyngitis, headache, hypoglycemia, constipation, weakness, muscle pain, limb pain, back pain, pruritus, decreased appetite, itching, dizziness, thrombocytopenia, mental disorders (anorexia), metabolic and nutritional disorders (weight loss), severe and disabling arthralgia

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius. This will help preserve the medication's effectiveness for a longer period.

Appearance

Bright pink oval film-coated tablet

Package unit

30 tablets/box[(10 tablets/PTP x 3)]